The PI3K-mTOR pathway is involved in regulating all hallmarks of cancer, and is often dysregulated in
NSCLC, making it an attractive therapeutic target in this setting. Acquired resistance to PI3K-mTOR
inhibition is a major hurdle to overcome in the success of PI3K-mTOR targeted agents. H460, A549, and
H1975 resistant cells were generated by prolonged treatment in culture with Apitolisib (GDC-0980), a
dual PI3K-mTOR inhibitor over a period of several months, from age-matched parent cells. Resistance
was deemed to have developed when a log fold diference in IC50 had been achieved. Resistant cell
lines also exhibited resistance to another widely investigated PI3K-mTOR dual inhibitor; Dactolisib
(BEZ235). Cell lines were characterised at the level of mRNA (expression array profling expression
of >150 genes), miRNA (expression array profling of 2100 miRNAs), protein (bottoms-up label-free
mass spectrometry) and phosphoprotein (expression array profling of 84 phospho/total proteins).
Key alterations were validated by qPCR and Western blot. H1975 cells were initially most sensitive to
Apitolisib (GDC-0980), but developed resistance more quickly than the other cell lines, perhaps due to
increased selective pressure from the impressive initial efect. In-depth molecular profling suggested
epithelial-mesenchymal transition (EMT) may play a role in resistance to PI3K-mTOR dual inhibition in
NSCLC.
Ireland ->
Trinity College Dublin ->
RSS Feeds
Ireland ->
Maynooth University ->
Academic Unit = Faculty of Science and Engineering: Biology
Ireland ->
Maynooth University ->
Status = Published
Ireland ->
Trinity College Dublin ->
School of Medicine
Ireland ->
Maynooth University ->
Open Access DRIVERset
Ireland ->
Maynooth University ->
Type = Article
Ireland ->
Maynooth University ->
Academic Unit = Faculty of Science and Engineering
Ireland ->
Trinity College Dublin ->
Clinical Medicine
Ireland ->
Trinity College Dublin ->
Clinical Medicine (Scholarly Publications)
Ireland ->
Trinity College Dublin ->
RSS Feeds
Kathy Gately,
Stephen P Finn,
Sinead Cuffe,
Stephen G Maher,
Niamh Kelly,
Gillian Moore,
Paul Dowling,
Ken O'Byrne,
Susan Heavey,
Martin Barr